Ardelyx (ARDX) Cash from Investing Activities (2013 - 2026)

Ardelyx (ARDX) reported Cash from Investing Activities of -$10.0 million for Q1 2026, down 450.58% on a YoY basis from $2.9 million in Q1 2025, and down 364.7% quarter-over-quarter from $3.8 million in Q4 2025.

Ardelyx (ARDX) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Ardelyx has reported Cash from Investing Activities for 14 years, with the latest figure at -$10.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 450.58% year-over-year to -$10.0 million; the trailing twelve-month figure through Mar 2026 stood at -$21.8 million (down 69.1% YoY), and the FY2025 full-year result was -$9.0 million, up 51.09% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$10.0 million, down from $3.8 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $34.9 million in Q2 2025, with the low at -$59.2 million in Q2 2023.
  • Historically, Cash from Investing Activities has averaged -$8.8 million across 5 years, with a median of -$832000.0 in 2022.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities tumbled 3829.93% — and 2025, when it jumped 210.85%.
  • Ardelyx's Cash from Investing Activities stood at $1.4 million in 2022, then slumped by 2151.84% to -$29.6 million in 2023, then sank by 40.77% to -$41.6 million in 2024, then surged by 109.07% to $3.8 million in 2025, then slumped by 364.7% to -$10.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$10.0 million (Q1 2026), $3.8 million (Q4 2025), and -$50.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn -10.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.00 Mn
Mar 31, 2026 -10.00 Mn
Dec 31, 2025 3.78 Mn
Dec 31, 2025 3.78 Mn
Sep 30, 2025 -50.51 Mn
Sep 30, 2025 -50.51 Mn
Jun 30, 2025 34.92 Mn
Jun 30, 2025 34.92 Mn
Mar 31, 2025 2.85 Mn
Mar 31, 2025 2.85 Mn
Dec 31, 2024 -41.62 Mn
Dec 31, 2024 -41.62 Mn
Sep 30, 2024 2.34 Mn
Sep 30, 2024 2.34 Mn
Jun 30, 2024 23.53 Mn
Jun 30, 2024 23.53 Mn
Mar 31, 2024 -2.57 Mn
Mar 31, 2024 -2.57 Mn
Dec 31, 2023 -29.57 Mn
Dec 31, 2023 -29.57 Mn